Showing results (771-780 of 863) with videos related to

Sort By:
Pageof 87
Neurobiology of Aging|November 29, 2021
Cerebrospinal fluid dynamics and discordant amyloid biomarkersJonathan Graff-Radford, David T Jones, Heather J Wiste, et al.
International Journal of Behavioral Medicine|May 11, 2011
Alpe d'HuZes cancer rehabilitation (A-CaRe) research: four randomized controlled exercise trials and economic evaluations in cancer patients and survivorsMai J M Chinapaw, Laurien M Buffart, Willem van Mechelen, et al.
British Journal of Clinical Pharmacology|February 10, 2019
Effects of prednisone on docetaxel pharmacokinetics in men with metastatic prostate cancer: A randomized drug-drug interaction studyBodine P S Belderbos, Koen G A M Hussaarts, Leonie J van Harten, et al.
ACS Photonics|September 4, 2018
Exciton Fine Structure and Lattice Dynamics in InP/ZnSe Core/Shell Quantum DotsAnnalisa Brodu, Mariana V Ballottin, Jonathan Buhot, et al.
Cell Reports|November 19, 2025
Structural basis of DNA-dependent coactivator recruitment by the tuft cell master regulator POU2F3Aktan Alpsoy, Jonathan J Ipsaro, Damianos Skopelitis, et al.
European Journal of Radiology|September 25, 2025
Hyperintense lesions suspect for acute cerebral microbleeds on ultra-high field T1 weighted 7 Tesla MRI in patients with cerebral amyloid angiopathyO F de Bruin, M R Schipper, E A Koemans, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 14, 2023
Microstructural white matter integrity in relation to vascular reactivity in Dutch-type hereditary cerebral amyloid angiopathyManon R Schipper, Naomi Vlegels, Thijs W van Harten, et al.
International Journal of Technology Assessment in Health Care|January 8, 2009
Constructive Technology Assessment (CTA) as a tool in coverage with evidence development: the case of the 70-gene prognosis signature for breast cancer diagnosticsValesca P Retèl, Jolien M Bueno-de-Mesquita, Marjan J M Hummel, et al.
Pharmacoeconomics|August 18, 2021
Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung CancerMartijn J H G Simons, Valesca P Retèl, Bram L T Ramaekers, et al.
Stroke|January 23, 2023
Sex Differences in Onset and Progression of Cerebral Amyloid AngiopathyEmma A Koemans, Juan Pablo Castello, Ingeborg Rasing, et al.
Pageof 87